| Filed On | Filing |
|---|---|
| 11 Mar 2026 |
Form 3: Wentworth Timothy C, Director
No securities owned |
| 20 May 2024 |
Form 3: Carter Robert B, Director
No securities owned |
| 19 May 2023 |
Form 3: Diaz Luis, Director
No securities owned |
| 22 Nov 2022 |
Form 3: Plewman Patrick, SVP for Diagnostic Services
Holds 8,924 shares of Common Stock |
| 22 Nov 2022 |
Form 3: Kuppusamy Karthik, SVP, Clinical Solutions
Holds 7,960 shares of Common Stock |
| 22 Nov 2022 |
Form 3: Gardner Mark A, SVP of Molecular Gen & Oncol
Holds 1,002 shares of Common Stock |
| 22 Nov 2022 |
Form 3: Delaney Mark E, SVP & Chief Commercial Officer
Holds 1,731 shares of Common Stock |
| 26 Jul 2022 |
Form 3: Samad Sam, Executive Vice President & CFO
Holds 15,674 shares of Common Stock |
| 17 Aug 2021 |
Form 3: Doi Tracey, Director
No securities owned |
| 16 Mar 2020 |
Form 3: Lassiter Wright Iii, Director
No securities owned |
| 21 Nov 2019 |
Form 3: Mendez Manuel O., SVP & Chief Commercial Officer
Holds 24,626 shares of Common Stock |
| 03 Apr 2019 |
Form 3: Deppe Michael J, VP, Corp. Controller & CAO
Holds 23,558 shares of Common Stock |
| 20 Feb 2019 |
Form 3: Morrison Denise M, Director
No securities owned |
| 17 May 2018 |
Form 3: Torley Helen, Director
No securities owned |
| 21 Feb 2017 |
Form 3: Eglinton Manner Carrie, SVP, Advanced Diagnostics
Holds 17,405 shares of Common Stock |
| 19 Aug 2015 |
Form 3: Klug Robert A, VP, Corporate Controller
Holds 1,749 shares of Common Stock |
| 01 Dec 2014 |
Form 3: Leiden Jeffrey M, Director
No securities owned |
| 24 Jul 2014 |
Form 3: Gregg Vicky B, Director
No securities owned |
| 18 Feb 2014 |
Form 3: Davis J. E., SVP, Operations
Holds 22,439 shares of Common Stock |
| 13 Jan 2014 |
Form 3: Main Timothy L, Director
No securities owned |
Loading...
